COR
Cencora Inc.

896
Mkt Cap
$63.7B
Volume
1.2M
52W High
$331.94
52W Low
$223.92
PE Ratio
33.80
COR Fundamentals
Price
$328.56
Prev Close
$330.80
Open
$330.30
50D MA
$303.34
Beta
0.07
Avg. Volume
1.81M
EPS (Annual)
$7.53
P/B
32.17
Rev/Employee
$6.39M
Loading...
Loading...
News
all
press releases
Universal Health to Report Q3 Earnings: Key Estimates to Note
UHS is likely to have posted Q3 revenue and earnings growth, driven by strong hospital and behavioral health segments despite cost pressures.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?
Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·3d ago
News Placeholder
IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes
IntrinsiQ Specialty Solutions (IntrinsiQ), a leader in data analytic solutions, and part of Cencora, can now offer expanded data and insights for oncology, retina and other therapeutic areas. As part...
Business Wire·8d ago
News Placeholder
Here's Why Cencora (COR) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·11d ago
News Placeholder
McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio
MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-Surgical unit.
Zacks·16d ago
News Placeholder
Why Cencora (COR) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·28d ago
News Placeholder
Top Analyst Reports for Apple, Eli Lilly & Chevron
Apple grows Services with over 1B subscribers, while Eli Lilly and Chevron face mixed industry and market dynamics.
Zacks·1mo ago
News Placeholder
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·1mo ago
News Placeholder
PACS Group, Inc. (PACS) Soars 24.5%: Is Further Upside Left in the Stock?
PACS Group, Inc. (PACS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·1mo ago
News Placeholder
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·1mo ago

Latest COR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.